
Roohi Peter
Reporter at Labiotech
I write articles on healthcare, biotech, pharma, science, and financing for the digital news website Labiotech
Publications
- Labiotech.eu5 articles
- Global Risk Regulator
Writes Most On
- Depression drug trials are failing—and placebos are to blame21 Mar—Labiotech.euPhoto credits: Miikka Luotio (Unsplash) Subscribe to our newsletter to get the latest biotech news! By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.* Business email* Depression affects around 5% of the global population, with antidepressants commonly prescribed to manage conditions like major depressive disorder, seasonal affective disorder, persistent depressive disorder, and bipolar depression....
- Trade war: how new U.S. tariffs will impact the biopharma industry19 Feb—Labiotech.euPhoto credits: Shirly Niv Marton (Unsplash) Subscribe to our newsletter to get the latest biotech news! By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.* Business email* When U.S. President Donald Trump declared trade tariffs two weeks ago, it led to a global frenzy over a potential trade war. While the 25% tariffs imposed on Canada and Mexico have been shelved for a month, a 10% tariff was...
- World Cancer Day: trends in cancer therapeutics to look forward to in 20254 Feb—Labiotech.euPhoto credits: Tara Winstead (Pexels) Subscribe to our newsletter to get the latest biotech news! By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.* Business email* Cancer has long been one of the most persistent and deadly diseases, and with its ability to evolve, resist treatment, and spread relentlessly, it has left scientists grappling for solutions. Yet, amid the uncertainty, the landscape of...